BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12639980)

  • 1. HIF hydroxylation and the mammalian oxygen-sensing pathway.
    Safran M; Kaelin WG
    J Clin Invest; 2003 Mar; 111(6):779-83. PubMed ID: 12639980
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
    Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
    IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Much huffing about HIF: oxygen dependent proline hydroxylation and the regulation of hypoxia inducible factors.
    Robinson B
    Pediatr Res; 2001 Dec; 50(6):673. PubMed ID: 11726718
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
    Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
    Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
    Cockman ME; Masson N; Mole DR; Jaakkola P; Chang GW; Clifford SC; Maher ER; Pugh CW; Ratcliffe PJ; Maxwell PH
    J Biol Chem; 2000 Aug; 275(33):25733-41. PubMed ID: 10823831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer. Many vessels, faulty gene.
    Kaelin WG
    Nature; 1999 May; 399(6733):203-4. PubMed ID: 10353237
    [No Abstract]   [Full Text] [Related]  

  • 9. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
    Pugh CW; Ratcliffe PJ
    Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targets from VHL studies into the oxygen-sensing pathway.
    Maynard MA; Ohh M
    Curr Cancer Drug Targets; 2005 Aug; 5(5):345-56. PubMed ID: 16101382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.
    Sang N; Fang J; Srinivas V; Leshchinsky I; Caro J
    Mol Cell Biol; 2002 May; 22(9):2984-92. PubMed ID: 11940656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
    Masson N; Ratcliffe PJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K; Makino Y; Pereira T; Poellinger L
    EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
    Barry RE; Krek W
    Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900
    [No Abstract]   [Full Text] [Related]  

  • 16. VHL takes HIF's breath away.
    Krek W
    Nat Cell Biol; 2000 Jul; 2(7):E121-3. PubMed ID: 10878820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.
    Mole DR; Pugh CW; Ratcliffe PJ; Maxwell PH
    Adv Enzyme Regul; 2002; 42():333-47. PubMed ID: 12123724
    [No Abstract]   [Full Text] [Related]  

  • 18. Proline hydroxylation and gene expression.
    Kaelin WG
    Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.
    Ivan M; Kondo K; Yang H; Kim W; Valiando J; Ohh M; Salic A; Asara JM; Lane WS; Kaelin WG
    Science; 2001 Apr; 292(5516):464-8. PubMed ID: 11292862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen sensors and angiogenesis.
    Maxwell PH; Ratcliffe PJ
    Semin Cell Dev Biol; 2002 Feb; 13(1):29-37. PubMed ID: 11969369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.